An algorithm for thorough background subtraction from high‐resolution LC/MS data: application to the detection of troglitazone metabolites in rat plasma, bile, and urine
- 2 June 2008
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 43 (9), 1191-1200
- https://doi.org/10.1002/jms.1432
Abstract
Interferences from biological matrices remain a major challenge to the in vivo detection of drug metabolites. For the last few decades, predicted metabolite masses and fragmentation patterns have been employed to aid in the detection of drug metabolites in liquid chromatography/mass spectrometry (LC/MS) data. Here we report the application of an accurate mass‐based background‐subtraction approach for comprehensive detection of metabolites formed in vivo using troglitazone as an example. A novel algorithm was applied to check all ions in the spectra of control scans within a specified time window around an analyte scan for potential background subtraction from that analyte spectrum. In this way, chromatographic fluctuations between control and analyte samples were dealt with, and background and matrix‐related signals could be effectively subtracted from the data of the analyte sample. Using this algorithm with a ± 1.0 min control scan time window, a ± 10 ppm mass error tolerance, and respective predose samples as controls, troglitazone metabolites were reliably identified in rat plasma and bile samples. Identified metabolites included those reported in the literature as well as some that had not previously been reported, including a novel sulfate conjugate in bile. In combination with mass defect filtering, this algorithm also allowed for identification of troglitazone metabolites in rat urine samples. With a generic data acquisition method and a simple algorithm that requires no presumptions of metabolite masses or fragmentation patterns, this high‐resolution LC/MS‐based background‐subtraction approach provides an efficient alternative for comprehensive metabolite identification in complex biological matrices. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Direct-injection screening for acidic drugs in plasma and neutral drugs in equine urine by differential-gradient LC–LC coupled MS/MSJournal of Chromatography B, 2007
- Detection and Characterization of Metabolites in Biological Matrices Using Mass Defect Filtering of Liquid Chromatography/High Resolution Mass Spectrometry DataPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2006
- Accurate mass filtering of ion chromatograms for metabolite identification using a unit mass resolution liquid chromatography/mass spectrometry systemRapid Communications in Mass Spectrometry, 2006
- In vivo metabolite detection and identification in drug discovery via LC‐MS/MS with data‐dependent scanning and postacquisition data miningJournal of Mass Spectrometry, 2005
- Rapid detection and characterization of minor reactive metabolites using stable-isotope trapping in combination with tandem mass spectrometryRapid Communications in Mass Spectrometry, 2005
- A strategy for identification of drug metabolites from dried blood spots using triple‐quadrupole/linear ion trap hybrid mass spectrometryRapid Communications in Mass Spectrometry, 2005
- Bridging cheminformatic metabolite prediction and tandem mass spectrometryDrug Discovery Today, 2005
- Integration of Knowledge-Based Metabolic Predictions with Liquid Chromatography Data-Dependent Tandem Mass Spectrometry for Drug Metabolism Studies: Application to Studies on the Biotransformation of IndinavirAnalytical Chemistry, 2003
- A software filter to remove interference ions from drug metabolites in accurate mass liquid chromatography/mass spectrometric analysesJournal of Mass Spectrometry, 2003
- Peer Reviewed: Systematic LC/MS Metabolite Identification in Drug DiscoveryAnalytical Chemistry, 2001